156
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Key Common Genes in Obstructive Sleep Apnea and Lung Cancer are Associated with Prognosis of Lung Cancer Patients

ORCID Icon, , , , &
Pages 5381-5396 | Published online: 07 Sep 2021

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
  • Yang D, Liu Y, Bai C, Wang X, Powell CA. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett. 2020;468:82–87. doi:10.1016/j.canlet.2019.10.009
  • Bade BC, Dela CC. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24. doi:10.1016/j.ccm.2019.10.001
  • Rundo JV. Obstructive sleep apnea basics. Cleve Clin J Med. 2019;86(9Suppl 1):2–9. doi:10.3949/ccjm.86.s1.02
  • Yang X, Niu X, Xiao Y, Lin K, Chen X. MiRNA expression profiles in healthy OSAHS and OSAHS with arterial hypertension: potential diagnostic and early warning markers. Respir Res. 2018;19(1):194. doi:10.1186/s12931-018-0894-9
  • Ko CY, Liu QQ, Su HZ, et al. Gut microbiota in obstructive sleep apnea-hypopnea syndrome: disease-related dysbiosis and metabolic comorbidities. Clin Sci (Lond). 2019;133(7):905–917. doi:10.1042/CS20180891
  • Huang T, Lin BM, Stampfer MJ, et al. Associations of self-reported obstructive sleep apnea with total and site-specific cancer risk in older women: a prospective study. Sleep. 2020;16(7):1091–1098. doi:10.1093/sleep/zsaa198
  • Cabezas E, Pérez-Warnisher MT, Troncoso MF, et al. Sleep disordered breathing is highly prevalent in patients with lung cancer: results of the sleep apnea in lung cancer study. Respiration. 2019;97(2):119–124. doi:10.1159/000492273
  • Seijo LM, Pérez-Warnisher MT, Giraldo-Cadavid LF, et al. Obstructive sleep apnea and nocturnal hypoxemia are associated with an increased risk of lung cancer. Sleep Med. 2019;63:41–45. doi:10.1016/j.sleep.2019.05.011
  • Torres M, Martinez-Garcia MÁ, Campos-Rodriguez F, et al. Lung cancer aggressiveness in an intermittent hypoxia murine model of postmenopausal sleep apnea. Menopause. 2020;27(6):706–713. doi:10.1097/GME.0000000000001526
  • Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9(1):559. doi:10.1186/1471-2105-9-559
  • Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4(1):17. doi:10.2202/1544-6115.1128
  • Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
  • Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389(10066):299–311. doi:10.1016/S0140-6736(16)30958-8
  • Li L, Lu J, Xue W, et al. Target of obstructive sleep apnea syndrome merge lung cancer: based on big data platform. Oncotarget. 2017;8(13):21567–21578. doi:10.18632/oncotarget.15372
  • Zhu Y, Ding X, She Z, et al. Exploring shared pathogenesis of Alzheimer’s disease and type 2 diabetes mellitus via co-expression networks analysis. Curr Alzheimer Res. 2020;17(6):566–575. doi:10.2174/1567205017666200810164932
  • Sezin T, Vorobyev A, Sadik CD, Zillikens D, Gupta Y, Ludwig RJ. Gene expression analysis reveals novel shared gene signatures and candidate molecular mechanisms between pemphigus and systemic lupus erythematosus in CD4(+) T cells. Front Immunol. 2017;8:1992. doi:10.3389/fimmu.2017.01992
  • Stiefel P, Sánchez-Armengol MA, Villar J, Vallejo-Vaz A, Moreno-Luna R, Capote F. Obstructive sleep apnea syndrome, vascular pathology, endothelial function and endothelial cells and circulating microparticles. Arch Med Res. 2013;44(6):409–414. doi:10.1016/j.arcmed.2013.08.005
  • Hoffmann M, Wolf J, Szyndler A, Singh P, Somers VK, Narkiewicz K. Serum of obstructive sleep apnea patients impairs human coronary endothelial cell migration. Arch Med Sci. 2017;13(1):223–227. doi:10.5114/aoms.2015.56490
  • Chen J, Liu A, Wang Z, et al. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression. Mol Cancer. 2020;19(1):98. doi:10.1186/s12943-020-01217-2
  • Ma SC, Li Q, Peng JY, et al. Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis. CNS Neurosci Ther. 2017;23(12):947–960. doi:10.1111/cns.12764
  • Law J, Yu VC, Baksh S. Modulator of Apoptosis 1: a highly regulated RASSF1A-interacting BH3-like protein. Mol Biol Int. 2012;2012:536802. doi:10.1155/2012/536802
  • Law J, Kwek I, Svystun O, et al. RACK1/TRAF2 regulation of modulator of apoptosis-1 (MOAP-1). Biochim Biophys Acta Mol Cell Res. 2018;1865(5):684–694. doi:10.1016/j.bbamcr.2018.02.006
  • Wu T, Chen W, Kong D, et al. miR-25 targets the modulator of apoptosis 1 gene in lung cancer. Carcinogenesis. 2015;36(8):925–935. doi:10.1093/carcin/bgv068
  • Forzati F, Federico A, Pallante P, Fedele M, Fusco A. Tumor suppressor activity of CBX7 in lung carcinogenesis. Cell Cycle. 2012;11(10):1888–1891. doi:10.4161/cc.20022
  • Forzati F, Federico A, Pallante P, et al. CBX7 is a tumor suppressor in mice and humans. J Clin Invest. 2012;122(2):612–623. doi:10.1172/JCI58620
  • Cacciola NA, Sepe R, Forzati F, et al. Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment. Naunyn Schmiedebergs Arch Pharmacol. 2015;388(11):1179–1186. doi:10.1007/s00210-015-1153-y
  • Pallante P, Sepe R, Federico A, Forzati F, Bianco M, Fusco A. CBX7 modulates the expression of genes critical for cancer progression. PLoS One. 2014;9(5):e98295. doi:10.1371/journal.pone.0098295
  • Peng X, Guan L, Gao B. miRNA-19 promotes non–small-cell lung cancer cell proliferation via inhibiting CBX7 expression. Onco Targets Ther. 2018;11:8865–8874. doi:10.2147/OTT.S181433
  • Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 2004;15(4):197–204. doi:10.1016/j.cytogfr.2004.03.007
  • Wagner KD, Du S, Martin L, Leccia N, Michiels JF, Wagner N. Vascular PPARβ/δ promotes tumor angiogenesis and progression. Cells-Basel. 2019;8(12):1623. doi:10.3390/cells8121623
  • Reinmuth N, Rensinghoff S, Raedel M, et al. Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells. Int J Oncol. 2007;31(3):621–626.
  • Donnem T, Andersen S, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM. Prognostic impact of angiogenic markers in non–small-cell lung cancer is related to tumor size. Clin Lung Cancer. 2011;12(2):106–115. doi:10.1016/j.cllc.2011.03.005
  • Donnem T, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM. Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer. Ann Oncol. 2010;21(2):223–231. doi:10.1093/annonc/mdp296
  • Park JC, Chae YK, Son CH, et al. Epigenetic silencing of human T (brachyury homologue) gene in non–small-cell lung cancer. Biochem Biophys Res Commun. 2008;365(2):221–226. doi:10.1016/j.bbrc.2007.10.144
  • Gurtner A, Starace G, Norelli G, Piaggio G, Sacchi A, Bossi G. Mutant p53-induced up-regulation of mitogen-activated protein kinase 3 contributes to gain of function. J Biol Chem. 2010;285(19):14160–14169. doi:10.1074/jbc.M109.094813
  • Willumsen N, Bager CL, Leeming DJ, Bay-Jensen AC, Karsdal MA. Nidogen-1 degraded by cathepsin S can be quantified in serum and is associated with non–small cell lung cancer. Neoplasia. 2017;19(4):271–278. doi:10.1016/j.neo.2017.01.008
  • Matsuo Y, Hashimoto S, Koga T, et al. Growth pattern correlates with the distribution of basement membrane and prognosis in lung adenocarcinoma. Pathol Res Pract. 2004;200(7–8):517–529. doi:10.1016/j.prp.2004.05.002